English  |  正體中文  |  简体中文  |  總筆數 :2875249  
造訪人次 :  54222126    線上人數 :  1369
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 		 
搜尋範圍 進階搜尋
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR
計畫說明

瀏覽
典藏機構
作者
題名
日期
統計圖表
機構即時統計
學術趨勢

消息
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

著作權
出版社及期刊政策查詢
TAIR著作權會議記錄

相關連結
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
臺灣機構典藏 TAIR >  依作者瀏覽

"| kao j h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 46-55 / 71 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-07-12T02:44:30Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Liu C.-H; | Huang Y.-J; | Yang S.-S; | Chang C.-H; | Yang S.-S; | Sun H.-Y; | Liu C.-J; | Liu W.-C; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Hung C.-C; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Liu C.-J; | Tseng T.-C; | Yang W.-T; | Su T.-H; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Liu C.-H; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:28Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:27Z Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis Liu C.-H; | Shih Y.-L; | Yang S.-S; | Lin C.-L; | Fang Y.-J; | Cheng P.-N; | Chen C.-Y; | Peng C.-Y; | Hsieh T.-Y; | Chiu Y.-C; | Su T.-H; | Liu C.-J; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:27Z Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection Liu C.-H; | Su T.-H; | Liu C.-J; | Hong C.-M; | HUNG-CHIH YANG; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:26Z Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Chou S.-W; | Lin C.-H; | Liu C.-H; | Liu C.-J; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:26Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H; | Liao S.-H; | Hong C.-M; | Liu C.-J; | Tseng T.-C; | Liu C.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Adhoute X; | Bourli?re M; | Kao J.-H.

顯示項目 46-55 / 71 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team